Significantly lower levels of cytoplasmic ZYX in NSCLC and SCC cells were demonstrated in Stage III–IV compared with Stage I (* p < 0.05, for both) (Figure 11A,B). Here, ZYX is linked to non-small cell lung carcinoma.